Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 6/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.48 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.47 |
| ▸ | F10 | P00742 | 10/20 | 0.43 |
| ▸ | F7 | P08709 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 5/20 | 0.42 |
| ▸ | GRIN2D | O15399 | 3/20 | 0.40 |
| ▸ | GRIN3B | O60391 | 3/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.40 |
| ▸ | GRIN2A | Q12879 | 3/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.40 |
| ▸ | GRIN2C | Q14957 | 3/20 | 0.40 |
| ▸ | GRIN3A | Q8TCU5 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7083824 | 0.88 | PRSS1 (0.51) | PRSS1PRSS2PRSS3LOXL2F10 | |
| SCHEMBL7090040 | 0.85 | MEP1B (0.43) | MEN1KMT2A | |
| SCHEMBL677191 | 0.80 | MEN1 (0.59) | MEN1KMT2A | |
| SCHEMBL7089972 | 0.80 | F10 (0.45) | PRSS1PRSS2PRSS3LOXL2F10 | |
| SCHEMBL7090549 | 0.79 | GRIN2D (0.57) | PRSS1PRSS2PRSS3LOXL2F10 | |
| SCHEMBL7083845 | 0.78 | MEN1 (0.56) | PRSS1PRSS2PRSS3LOXL2F10 | |
| SCHEMBL7084315 | 0.78 | GRIN2D (0.60) | PRSS1PRSS2PRSS3LOXL2F10 | |
| SCHEMBL7089328 | 0.76 | PRSS1 (0.61) | PRSS1PRSS2PRSS3LOXL2F10 | |
| SCHEMBL14662383 | 0.76 | PRSS1 (0.57) | PRSS1PRSS2PRSS3LOXL2F10 | |
| SCHEMBL7083226 | 0.76 | GRIN2D (0.59) | PRSS1PRSS2PRSS3LOXL2F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030199698-A1 | Carbamic acid esters as inhibitors of factor xa | MERCK PATENT GMBH (DE) | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199698-A1 | Carbamic acid esters as inhibitors of factor xa | F11, F12, F13A1 | PRSS1 102/4885PRSS2 295/4885PRSS3 628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.